FDA told more study on testosterone treatments needed; AbbVie's AndroGel a leading product in that niche

An expert panel recommended that the Food and Drug Administration tighten restrictions on the use of testosterone drugs, a move that could put a dent in sales of one of AbbVie’s billion-dollar drugs...